Follow the 인트론바이오 stock price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares are quoted on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 인트론바이오 has published 37 public disclosures. Market capitalisation: €79.5bn. The latest transaction was reported on 3 July 2026 (Purchase). Among the most active insiders: 윤성준. Every trade is openly available.
37
Insider Decl.
n/a
Thresholds
n/a
15 ops.
Buy Volume
n/a
6 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 23,215 of 29,062 companies
30.8
score / 100
Value
17
Quality
45
FCF yld-8.7%
Earn yld-10%
EV/EBITDA·
ROE-12%
Gross mgn54%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
인트론바이오 es una empresa especializada en el sector de la salud y farmacéutico, que cotiza en el mercado XKRX. Se centra en el desarrollo de soluciones biofarmacéuticas innovadoras.